rs11735845

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001364905.1(LRBA):​c.4485C>T​(p.Gly1495Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0281 in 1,603,164 control chromosomes in the GnomAD database, including 803 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 51 hom., cov: 32)
Exomes 𝑓: 0.029 ( 752 hom. )

Consequence

LRBA
NM_001364905.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.242

Publications

6 publications found
Variant links:
Genes affected
LRBA (HGNC:1742): (LPS responsive beige-like anchor protein) The protein encoded by this gene is a member of the WDL-BEACH-WD (WBW) gene family. Its expression is induced in B cells and macrophages by bacterial lipopolysaccharides (LPS). The encoded protein associates with protein kinase A and may be involved in leading intracellular vesicles to activated receptor complexes, which aids in the secretion and/or membrane deposition of immune effector molecules. Defects in this gene are associated with the disorder common variable immunodeficiency-8 with autoimmunity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
LRBA Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to LRBA deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.015).
BP6
Variant 4-150844184-G-A is Benign according to our data. Variant chr4-150844184-G-A is described in ClinVar as Benign. ClinVar VariationId is 403051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.242 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0208 (3159/151698) while in subpopulation NFE AF = 0.0319 (2169/67914). AF 95% confidence interval is 0.0308. There are 51 homozygotes in GnomAd4. There are 1495 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 51 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRBANM_001364905.1 linkc.4485C>T p.Gly1495Gly synonymous_variant Exon 28 of 57 ENST00000651943.2 NP_001351834.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRBAENST00000651943.2 linkc.4485C>T p.Gly1495Gly synonymous_variant Exon 28 of 57 NM_001364905.1 ENSP00000498582.2 A0A494C1L5

Frequencies

GnomAD3 genomes
AF:
0.0208
AC:
3158
AN:
151584
Hom.:
51
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00594
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0193
Gnomad ASJ
AF:
0.00721
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00833
Gnomad FIN
AF:
0.0271
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0319
Gnomad OTH
AF:
0.0202
GnomAD2 exomes
AF:
0.0206
AC:
5167
AN:
251252
AF XY:
0.0210
show subpopulations
Gnomad AFR exome
AF:
0.00610
Gnomad AMR exome
AF:
0.0145
Gnomad ASJ exome
AF:
0.00675
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0283
Gnomad NFE exome
AF:
0.0305
Gnomad OTH exome
AF:
0.0211
GnomAD4 exome
AF:
0.0289
AC:
41946
AN:
1451466
Hom.:
752
Cov.:
30
AF XY:
0.0280
AC XY:
20252
AN XY:
722452
show subpopulations
African (AFR)
AF:
0.00504
AC:
168
AN:
33326
American (AMR)
AF:
0.0151
AC:
674
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00689
AC:
179
AN:
25978
East Asian (EAS)
AF:
0.0000758
AC:
3
AN:
39574
South Asian (SAS)
AF:
0.00985
AC:
841
AN:
85348
European-Finnish (FIN)
AF:
0.0268
AC:
1426
AN:
53170
Middle Eastern (MID)
AF:
0.00802
AC:
46
AN:
5738
European-Non Finnish (NFE)
AF:
0.0336
AC:
37066
AN:
1103714
Other (OTH)
AF:
0.0258
AC:
1543
AN:
59912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1675
3351
5026
6702
8377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1376
2752
4128
5504
6880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0208
AC:
3159
AN:
151698
Hom.:
51
Cov.:
32
AF XY:
0.0202
AC XY:
1495
AN XY:
74070
show subpopulations
African (AFR)
AF:
0.00592
AC:
245
AN:
41382
American (AMR)
AF:
0.0192
AC:
293
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.00721
AC:
25
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00834
AC:
40
AN:
4796
European-Finnish (FIN)
AF:
0.0271
AC:
283
AN:
10432
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0319
AC:
2169
AN:
67914
Other (OTH)
AF:
0.0200
AC:
42
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
149
297
446
594
743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
106
Bravo
AF:
0.0203
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Combined immunodeficiency due to LRBA deficiency Benign:2
Oct 19, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, silent variant not in splice consensus -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
10
DANN
Benign
0.62
PhyloP100
-0.24
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11735845; hg19: chr4-151765336; API